ADPTAdaptive Biotechnologies Corpvs its industry peers
A metric-by-metric comparison of Adaptive Biotechnologies Corp against SIC 2836 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADPTThis | $4.4B#5 | — | 30.9x#5 | 16.0x#1 | 54.8%#3 | 62.7%#1 | -20.6%#1 | -41.6%#4 | — | — | 114.7%#3 | — |
| PCVX | $8.7B#1 | — | 3.2x#1 | — | — | -65.2%#5 | — | -0.0%#1 | — | — | 88.2%#5 | — |
| IBRX | $8.4B#2 | — | — | 74.1x#2 | 668.3%#1 | 15.0%#3 | -226.0%#2 | — | — | — | 182.4%#1 | — |
| IMVT | $7.5B#3 | — | 10.2x#4 | — | — | -22.2%#4 | — | -68.8%#5 | — | — | 138.2%#2 | — |
| CGON | $6.6B#4 | — | 6.4x#3 | 1627.1x#4 | 254.7%#2 | -82.9%#6 | -4722.1%#4 | -15.6%#2 | -18.8%#1 | — | 107.2%#4 | — |
| RLAY | $4.1B#6 | — | 4.6x#2 | 269.0x#3 | 53.4%#4 | 18.1%#2 | -1971.6%#3 | -31.1%#3 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2836). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice